Impact of immunosuppression and acute rejection on hepatitis B recurrence

Transplant Proc. 1997 Feb-Mar;29(1-2):509-10. doi: 10.1016/s0041-1345(96)00241-2.

Authors

K P Platz¹, A R Mueller, G W Haller, T Berg, R Neuhaus, W O Bechstein, U Hopf, H Lobeck, P Neuhaus

Affiliation

¹ Department of Surgery, Virchow Clinic, Humboldt University Berlin, Germany.

PMID: 9123107
DOI: 10.1016/s0041-1345(96)00241-2

No abstract available

MeSH terms

Cyclosporine / therapeutic use
Drug Therapy, Combination
Graft Rejection / drug therapy
Graft Rejection / epidemiology
Graft Rejection / immunology*
Graft Survival*
Hepatitis B / immunology*
Hepatitis B / surgery*
Hepatitis B / therapy
Humans
Immunization, Passive*
Immunoglobulins
Immunosuppression Therapy*
Immunosuppressive Agents / therapeutic use
Incidence
Liver Transplantation / immunology*
Liver Transplantation / mortality
Liver Transplantation / pathology
Tacrolimus / therapeutic use

Substances

Immunoglobulins
Immunosuppressive Agents
Cyclosporine
Tacrolimus
hepatitis B hyperimmune globulin